Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Live Terminal
Health · Full coverage

Wegovy Trial Shows Significant Weight Loss in Children Aged 6-12

How 2 Israeli newsrooms covered this story — translated into English and compared side by side.

100% center
Center 2

By יואב אבן

First reported by N12 · 3 hours ago

What happened

A global trial of the weight-loss drug Wegovy in children aged 6-12 showed significant BMI reduction, with over 40% achieving normal weight after 68 weeks. The drug's safety profile in children was found to be similar to adults, with common side effects like nausea and constipation.

  • 01Wegovy trial shows significant weight loss in children aged 6-12.
  • 02Over 40% of child participants achieved normal weight after 68 weeks.
  • 0316 Israeli children participated in the international study.
  • 04Drug's safety in children mirrors that seen in adults.
  • 05Hope expressed for inclusion in Israel's health basket.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story
People
OrganizationsNovo Nordisk, Rambam Medical Center, Schneider Children's Medical Center, Shamir Medical Center
PlacesIsrael, Washington

Full coverage · 2 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

N12Center · Hebrew3 hours ago
Wegovy Trial Shows Significant Weight Loss in Children Aged 6-12
MakoCenter · Hebrew3 hours ago
Wegovy Trial Shows Significant Weight Loss in Children Aged 6-12

Related stories

Obesity Drug Shows Promising Results in Young Children Study3 hours agoNew Weight Loss Injections Transform Lives and Challenge Slimness CultureJul 8, 2026New Guidelines Advise Against GLP-1 Weight Loss Drugs During Pregnancy but Allow Early ExposureAug 2, 2026US Study Reveals Alarming 310-Fold Rise in Obesity Drug Prescriptions for Young Children1 day agoExperimental drug may help preserve muscle during weight loss injectionsJun 18, 2026Next-Generation Weight-Loss Drugs Aim Beyond the ScaleJun 26, 2026